ALKERMES | Aktywa



Assets Zmiana Data
AbbVie USD 136.17B 1B 2025-03
Acadia Pharmaceuticals USD 1.13B 55.39M 2025-03
ALKERMES USD 2.25B 170.83M 2025-06
Amgen USD 89.37B 2.47B 2025-03
Biogen USD 28.33B 297.1M 2025-06
BioMarin Pharmaceutical USD 7.46B 309.33M 2025-06
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Eli Lilly USD 89.39B 10.67B 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
Ionis Pharmaceuticals USD 2.99B 172.18M 2025-06
J&J USD 193.67B 13.57B 2025-03
Malin Corporation EUR 198.5M 70.1M 2024-12
Merck USD 115.12B 1.98B 2025-03
Neurocrine Biosciences USD 3.89B 202.1M 2025-06
Otsuka Holdings JPY 3.79T 96.25B 2025-06
Pfizer USD 208.03B 5.37B 2025-03
Regeneron Pharmaceuticals USD 38.22B 674M 2025-06
Vertex Pharmaceuticals USD 24.04B 1.16B 2025-06


ALKERMES Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.